Rely on DRA to get your marketing message across while complying with marketing legislation, regulations and the industry’s Code of Ethics. DRA’s experienced team will write and review your marketing messages to ensure that they are both effective and in compliance in the Nordic region.
Our marketing compliance services include:
- Writing, preparing and assessing material based on legislation and, where applicable, the industry’s Codes of Ethics
- Reviews of claims on the basis of the Summary of Product Characteristics (SPC) and references
- Reviews of brochures, websites, health awareness information campaigns, applications, radio and television commercials, and social media and newspaper advertisements
- Reviews of marketing measures (including promotional events, hospitality, cooperation with patient organizations)
- Advice related to publication of financial ties
Rely on DRA’s experienced team to write and review your marketing initiatives. This will make it easy for you to guarantee that the marketing for your pharmaceutical products complies with marketing regulations and legislation. We’ll work together with your marketing team to ensure that your claims are accurate and stand up to scrutiny, and that your references are relevant across the Nordic region.
Our services for marketing compliance include writing marketing material, evaluating claims for pharmaceutical products and medicines, as well as for food supplements, medical devices and cosmetics and reviewing promotional material for different media channels. We can also review the medical aspects of your marketing initiatives, as well as accurately translating it into other languages.
Our team is familiar with the marketing legislation, regulations and industry Codes of Ethics in countries across the Nordics. They will help you navigate the different requirements in each country and find the best solutions for your medical product.
Our growth story continues – DRA Consulting to become part of the PharmaLex Group
DRA and PharmaLex are merging to create a centre of pharma and Health Tech expertise with nearly 3,000 experts. The merger will bring synergies for the customers of both companies while helping to accelerate Nordic cooperation in the pharmaceuticalmarket.
Press Release: PharmaLex expands Nordic footprint across key business units with DRA Consulting merger
PharmaLex expands Nordic footprint across key business units with DRA Consulting merger
New drug substances manufacturing site GMP certified thanks to DRA’s expertise
When building up a new drug substances manufacturing site, our client needed consultation on the GMP requirements, and to complement their own resources, a team of GMP and pharmaceutical chemical experts from DRA was set up.